Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Glycome Alterations in Psoriasis and an IgA Glycan Prediction Model of Disease Severity

ABSTRACT: Serum glycopeptide profiling using multiple reaction monitoring (MRM) mass spectrometry to identify psoriasis biomarkers

INSTRUMENT(S): 6490 Triple Quadrupole LC/MS

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Carlito B. Lebrilla Emanual Maverakis

PROVIDER: MSV000088072 | MassIVE |

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Low mass blood peptides discriminative of IBD severity

Project description:The enriched low mass proteome is unexplored as a source of differentiators for diagnosing and monitoring Inflammatory Bowel Disease (IBD) activity, less invasively than colonoscopy and histopathology. Differences in the enriched low mass plasma proteome (<25kDa) were assessed by label-free quantitative mass-spectrometry. A panel of marker candidates were progressed to validation phase and ‘Tier-2’ FDA-level validated quantitative assay. Proteins important in maintaining gut barrier function and homeostasis at the epithelial interface have been quantitated by Multiple Reaction Monitoring (MRM) in plasma and serum including both inflammatory rheumatoid arthritis controls (RA) and non-inflammatory healthy controls (C), ulcerative colitis (UC) and crohn’s disease (CD) patients. Detection by immunoblot confirmed presence at the protein level in serum. Correlation analysis and receiver operator characteristics were used to report the sensitivity and specificity. Five peptides discriminating IBD activity and severity had very little-to-no correlation to Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), white cell or platelet counts. Three of these peptides were found to be binding partners to SPP24 protein alongside other known matrix proteins. These Proteins have the potentially improve effective diagnosis and evaluate IBD activity, reducing the need for more invasive techniques.

2015-11-06 | PXD002821 | Pride

H3.3K27M HLA-A2 is not an effective immunotherapy target for diffuse midline glioma

Project description:The study investigated presentation of HLA A2 restricted H3.3K27M neopeptide using immunopeptidomics followed by DDA and/or targeted multiple monitoring reaction (MRM).

2023-10-24 | PXD038371 | Pride

MRM (Multiple Reaction Monitoring) quantitation of the blood plasma and serum samples from healthy donors

Project description:Using 30 synthetic bacterial peptides as external standards, we quantified the abundance of identified peptides in the serum and plasma by multiple reaction monitoring (MRM). Of these 30 peptides, 15 were quantified reliably.

2024-06-14 | PXD027793 | Pride

Enhancing glycopeptide annotation and glycan localization using the EAD implementation of hot electron capture dissociation through a multiplexed parallel reaction monitoring design of experiment

Project description:We present an optimized electron activated dissociation (EAD) methodology for liquid chromatography-tandem mass spectrometry (LC-MS/MS) based characterization of N- and O-glycopeptides. Recombinant human erythropoietin (rhEPO) was used as a model glycoprotein in this study. Applying a full factorial design of experiment (DoE) approach on the ZenoTOF 7600 instrument, we first optimized LC-MS parameters (i.e., ion spray voltage, ion source temperature, and active gradient time) to enhance glycopeptide ionization efficiency while reducing in-source fragmentation (ISF). Then, another DoE was performed for EAD parameter optimization. Multiplexed parallel reaction monitoring of one glycoform of each glycopeptide was performed to efficiently and comprehensively optimize the electron beam current, reaction time, and electron kinetic energy of the EAD set-up. Finally, the optimized EAD parameters were successfully applied in data-dependent acquisition (DDA) mode for the untargeted analysis of tryptic digests of rhEPO. Byonic and Mascot softwares were used to evaluate the potential of our optimized EAD setup against collision induced dissociation (CID), confirming that with EAD we improved glycan localization confidence while with CID a superior number of glycoforms were identified although with less confident glycan assignment.

2025-10-23 | PXD063177 | Pride

Proteomic analysis of human serum from patients with Chronic kidney disease

Project description:We applied two-dimensional fluorescence difference gel electrophoresis (2D DIGE) approach to separate depleted serum proteins in CKD and control serum. High abundance proteins were deleted to improve visualization of protein spots. After differentially expressed proteins were identified, these proteins were quantitated with multiple reaction monitoring (MRM) in the serum samples of patients (n=26) and control groups (n=10).

2019-04-16 | PXD013521 | JPOST Repository

Proteomics analysis of novel serum protein biomarkers for the diagnosis of trastuzumab-resistant breast cancer

Project description:we executed a study of serum proteome differences between trastuzumab-resistance and trastuzumab-response HER2-positive breast cancer patients using an isobaric TMT label-based multiplexed quantitative proteomic method in combination with a comprehensive functional bioinformatics analysis. An LC-MS/MS-based multiple/selective reaction monitoring (MRM/SRM) quantification method was applied to validate several candidate biomarkers.

2022-04-01 | PXD016655 | Pride

Esterification Reaction: An Unexpected Side Reaction During Glycopeptide and Glycan Storages in Formic Acid Solution

Project description:Glycosylation is one of the most important co- and post-translational modifications on proteins. In glycomics and glycoproteomics studies, the released glycans or intact glycopeptides are analyzed by tandem mass spectrometry to achieve their large-scale analyses. Prior to LC-MS/MS analyses, the glycan and intact glycopeptide samples are normally dissolved in formic acid (FA) solution, and sometimes stored at -20 °C or lower temperatures. In this study, we show that an unexpected +28 Da modification would occur in a time-dependent manner when the glycan and glycopeptide samples were stored in FA solution at -20 °C. Additional evidences suggested that this unexpected modification should be mainly caused by the esterification reaction between the hydroxyl group of glycans and FA. As this modification would reduce the glycopeptide identification and/or increase false positive results, once the glycan and glycopeptide samples have been dissolved in FA solution, it should not be stored at -20 °C.

2025-12-22 | PXD023448 | Pride

HST-MRM-MS: A Novel High-Sample-Throughput Multiple Reaction Monitoring Mass Spectrometric Method for Multiplex Absolute Quantitation of Hepatocellular Carcinoma Serum Biomarker

Project description:Absolute quantification of clinical biomarkers by mass spectrometry (MS) has been challenged due to low sample-throughput of current multiple reaction monitoring (MRM) methods. For this problem to be overcome, in this work, a novel high-sample-throughput multiple reaction monitoring mass spectrometric (HST-MRM-MS) quantification approach is developed to achieve simultaneous quantification of 24 samples. Briefly, triplex dimethyl reagents (L, M, and H) and eight-plex iTRAQ reagents were used to label the N- and C-termini of the Lys C-digested peptides, respectively. The triplex dimethyl labeling produces three coelute peaks in MRM traces, and the iTRAQ labeling produces eight peaks in MS2, resulting in 24 (3×8) channels in a single experiment. HST-MRM-MS has shown good accuracy (R2 > 0.98 for absolute quantification), reproducibility (RSD < 15%), and linearity (2–3 orders of magnitude). Moreover, the novel method has been successfully applied in quantifying serum biomarkers in hepatocellular carcinoma (HCC)-related serum samples. In conclusion, HST-MRM-MS is an accurate, high-sample-throughput, and broadly applicable MS-based absolute quantification method.

2020-02-23 | PXD040708 |

Human brain glycoform coregulation network and glycan modification alterations in Alzheimer's disease.

Project description:Despite the importance of protein glycosylation to brain health, current knowledge of glycosylated proteoforms or glycoforms in human brain and their alterations in Alzheimer's disease (AD) is limited. Here, we report a proteome-wide glycoform profiling study of human AD and control brains using intact glycopeptide-based quantitative glycoproteomics coupled with systems biology. Our study identified more than 10,000 human brain N-glycoforms from nearly 1200 glycoproteins and uncovered disease signatures of altered glycoforms and glycan modifications, including reduced sialylation and N-glycan branching and elongation as well as elevated mannosylation and N-glycan truncation in AD. Network analyses revealed a higher-order organization of brain glycoproteome into networks of coregulated glycoforms and glycans and discovered glycoform and glycan modules associated with AD clinical phenotype, amyloid-β accumulation, and tau pathology. Our findings provide valuable insights into disease pathogenesis and a rich resource of glycoform and glycan changes in AD and pave the way forward for developing glycosylation-based therapies and biomarkers for AD.

| S-EPMC10997212 | biostudies-literature

Risk factors for disease severity among children with Covid-19: a clinical prediction model.

Project description:BackgroundChildren account for a significant proportion of COVID-19 hospitalizations, but data on the predictors of disease severity in children are limited. We aimed to identify risk factors associated with moderate/severe COVID-19 and develop a nomogram for predicting children with moderate/severe COVID-19.MethodsWe identified children ≤ 12 years old hospitalized for COVID-19 across five hospitals in Negeri Sembilan, Malaysia, from 1 January 2021 to 31 December 2021 from the state's pediatric COVID-19 case registration system. The primary outcome was the development of moderate/severe COVID-19 during hospitalization. Multivariate logistic regression was performed to identify independent risk factors for moderate/severe COVID-19. A nomogram was constructed to predict moderate/severe disease. The model performance was evaluated using the area under the curve (AUC), sensitivity, specificity, and accuracy.ResultsA total of 1,717 patients were included. After excluding the asymptomatic cases, 1,234 patients (1,023 mild cases and 211 moderate/severe cases) were used to develop the prediction model. Nine independent risk factors were identified, including the presence of at least one comorbidity, shortness of breath, vomiting, diarrhea, rash, seizures, temperature on arrival, chest recessions, and abnormal breath sounds. The nomogram's sensitivity, specificity, accuracy, and AUC for predicting moderate/severe COVID-19 were 58·1%, 80·5%, 76·8%, and 0·86 (95% CI, 0·79 - 0·92) respectively.ConclusionOur nomogram, which incorporated readily available clinical parameters, would be useful to facilitate individualized clinical decisions.

| S-EPMC10259359 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data